LY3074828

BIOLOGICAL6 trials

Sponsors

Eli Lilly and Company

Conditions

Healthy

Phase 1

A Study of Two Different Formulations of LY3074828 in Healthy Participants

CompletedNCT03188510

Eli Lilly and CompanyHealthy

Start: 2017-06-30End: 2017-11-27Updated: 2024-01-25

A Study to Assess the Amount of LY3074828 That Gets Into the Body When Given With LY9999QS, in Healthy Participants

CompletedNCT03220126

Eli Lilly and CompanyHealthy

Start: 2017-07-17End: 2018-02-23Updated: 2018-03-29

A Study of LY3074828 in Healthy Participants

CompletedNCT03456713

Eli Lilly and CompanyHealthy

Start: 2018-03-06End: 2018-08-13Updated: 2024-02-20

A Study of Two Formulations of LY3074828 in Healthy Participants

CompletedNCT03662100

Eli Lilly and CompanyHealthy

Start: 2018-09-06End: 2019-01-25Updated: 2024-01-25

Study of LY3074828 in Healthy Participants

CompletedNCT03748940

Eli Lilly and CompanyHealthy

Start: 2018-10-10End: 2019-06-18Updated: 2019-07-19

A Study of Injections of LY3074828 in Healthy Participants

CompletedNCT03886948

Eli Lilly and CompanyHealthy

Start: 2019-03-27End: 2019-10-04Updated: 2024-02-20